Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Air Polishing With Ultrasonic Debridement in the Treatment of Initial Periodontal Pockets

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03863093
Recruitment Status : Completed
First Posted : March 5, 2019
Last Update Posted : May 14, 2020
Sponsor:
Information provided by (Responsible Party):
Syrian Private University

Brief Summary:
Clinical evaluation of using erythritol powder as air polishing with ultrasonic scaling and root planing in the treatment of initial periodontal pockets. This trial will be split-mouth design, in which each patient will receive traditional treatment (ultrasonic mechanical therapy and polishing) in one side, while the contralateral two quadrants of the jaws will be treated with erythritol powder by means of air polishing and ultrasonic scaling and root planing.

Condition or disease Intervention/treatment Phase
Gingivitis Device: Electro Medical Systems AIRFLOW® Device: Electro Medical Systems Piezo Not Applicable

Detailed Description:

The aim of the study is to evaluate the usage of erythritol powder by means of air polishing in hand of undergraduate dental students as a single way to remove biofilm and the adjunctive application of ultrasonic piezo afterward for calculus removal and root planing only in the treatment of initial periodontal pockets.

The sample size will be 15 patients. Initially, oral hygiene instructions with scaling and root planing will consist of the treatment phase. Each subject will be informed comprehensively about oral hygiene instructions using disclosing solution (such as erythrosine) and hand mirror. The participant will be shown modified bass technique and the proper usage of dental floss and appropriate interdental brushes.

The control side will be treated with supra- and subgingival ultrasonic piezo scalers then supragingival polishing with rubber cup and a special fluoride containing paste as a traditional way of removal of plaque and calculus, while the test side, will be confined to erythritol powder by means of air polishing as the only way to remove ultrasonic piezo scalers.

At the end of treatment, hand instruments may be used to ensure the smoothness 0f the teeth surfaces.

Clinical measurements will be performed at baseline and at 2 weeks, 4 and 6 weeks for the plaque index and gingival indices, whereas probing will be performed only after 6 weeks.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 13 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Clinical Outcomes of Using Erythritol Powder by Means of Air Polishing With Ultrasonic Debridement in the Treatment of Initial Periodontal Pockets in Hand of Dental Students: A Split-mouth, Randomized, Comparative, Controlled Study
Actual Study Start Date : February 9, 2019
Actual Primary Completion Date : September 30, 2019
Actual Study Completion Date : December 30, 2019

Arm Intervention/treatment
Experimental: An erythritol powder
An erythritol powder will be used by Electro Medical Systems AIRFLOW® and then Electro Medical Systems Piezo will be used for supra- and subgingival ultrasonic instrumentation
Device: Electro Medical Systems AIRFLOW®
An erythritol powder will be used by Electro Medical Systems AIRFLOW® and then Electro Medical Systems Piezo will be used for supra- and subgingival ultrasonic instrumentation

Device: Electro Medical Systems Piezo
Electro Medical Systems Piezo will be used for supra- and subgingival ultrasonic instrumentation

Active Comparator: ultrasonic instrumentation
Electro Medical Systems Piezo will be used for supra- and subgingival ultrasonic instrumentation
Device: Electro Medical Systems Piezo
Electro Medical Systems Piezo will be used for supra- and subgingival ultrasonic instrumentation




Primary Outcome Measures :
  1. change in the papillary bleeding index [ Time Frame: baseline, 2-weeks, 4-weeks, 6-weeks after the treatment ]

    Probing is performed in all four quadrants. A quadrant 1 is probed only from the oral aspect, quadrant 2 from the facial, 3 again from oral, and from the facial in quadrant 4

    Grade 1-Point: 20-30 seconds after probing the mesial and distal sulci with a periodontal probe, a single bleeding point is observed.

    Grade 2-Line/Points: A fine line of blood or several bleeding points become visible at the gingival margin.

    Grade 3-Triangle: The interdental triangle becomes more or less filled with blood.

    Grade 4-Drops: Profuse bleeding. Immediately after probing, blood flows into the interdental area to cover portions of the tooth and/or gingiva.

    Calculation:

    Papillary bleeding index= Bleeding Number/ Number of sites measured


  2. change in the percentage of study sites positive for bleeding on probing [ Time Frame: baseline, 6-weeks after the treatment ]

    All four surfaces of all teeth are assessed with regard to whether probing elicits bleeding (+) or not (-). The severity of gingivitis is expressed as a percentage.

    - no bleeding upon probing (not recorded)

    + bleeding upon probing

    Calculation:

    Bleeding on probing= Number of bleeding sites x100 / Number of sites evaluated



Secondary Outcome Measures :
  1. change in the full mouth Plaque Index [ Time Frame: baseline, 2-weeks, 4-weeks, 6-weeks after the treatment ]

    a score of 0 to 5 is assigned to each facial and lingual unrestored surface of all the teeth except third molars, as follows: The Plaque Index System

    Scores Criteria

    • 0 No plaque
    • 1 Separate flecks of plaque at the cervical margin of the tooth
    • 2 A thin continuous band of plaque (up to one mm) at the cervical margin of the tooth
    • 3 A band of plaque wider than one mm but covering less than one-third of the crown of the tooth
    • 4 Plaque covering at least one-third but less than two-thirds of the crown of the tooth
    • 5 Plaque covering two-thirds or more of the crown of the tooth

  2. change in the Calculus index [ Time Frame: baseline, 2-weeks, 4-weeks, 6-weeks after the treatment ]
    • 0, no calculus;
    • 1, mild supragingival calculus extending to marginal gingiva is present;
    • 2, moderate supra and subgingival calculus or only subgingival calculus is present; and
    • 3, excessive supra and subgingival calculus is present.

    it will be estimated visually


  3. change in the Modified Gingival Index [ Time Frame: baseline, 2-weeks, 4-weeks, 6-weeks after the treatment ]
    • 0 = Normal gingiva;
    • 1 = Mild inflammation - slight change in color and slight edema;
    • 2 = Moderate inflammation - redness, edema and glazing;
    • 3 = Severe inflammation - marked redness and edema, ulceration with tendency to spontaneous bleeding.

    it will be estimated visually


  4. change in the Probing pocket depth [ Time Frame: baseline, 6- weeks after the treatment ]
    measure as the change in distance from the gingival margin to the bottom of the gingival sulcus by using a periodontal probe (UNC 15 "University of North Carolina")

  5. The change of the root sensitivity [ Time Frame: baseline, 24- hours, 48- hours, 72-hours, 1- week, 2-weeks, 4-weeks, 6-weeks after the treatment ]
    will be evaluated using a visual analogue scale (VAS). The VAS root sensitivity scores ranges between 0 to 10. (0: no root sensitivity, 5: moderate root sensitivity, 10: severe root sensitivity).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Patients are in generally good health
  2. Patients are from both gender and their age is between 18 to 60 years.
  3. Patients have a minimum of 20 teeth
  4. The patient is a non-smoker (less than 5 cigarettes per day) and non-alcoholic.
  5. Female participants must not be pregnant or breastfeeding (lactation).
  6. the absence of severe oral habits
  7. the presence of at least one residual pocket with pocket depth >4 mm with interdental sites with a probing depth of 3 to 5 mm without furcation involvement or subgingival restorations.
  8. A sign informed consent from participation and permission to use obtained data for research purposes.

Exclusion Criteria:

  1. Bruxism
  2. Allergy to glycine or chlorhexidine;
  3. systemic medical conditions requiring antibiotic prophylaxis (for endocarditis prophylaxis) and anti-inflammatory drugs before dental procedures;
  4. active systemic infectious disease;
  5. major systemic illnesses (diabetes mellitus, cancer, immunodeficiency virus, bone metabolic diseases or disorders that compromise wound healing, radiation or immunosuppressive therapy, neutropenia, agranulocytosis, or bleeding disorders.
  6. chronic high dose steroid therapy
  7. Patients are undergone to radiotherapy or chemotherapy before or during the study period.
  8. actively smoking more than five cigarettes per day;
  9. signs of generalized severe periodontitis;
  10. having received periodontal maintenance within 3 months before baseline
  11. patients treated with antibiotics 6 months prior to the study
  12. chronic bronchitis and asthma
  13. compromised immune system
  14. hypersensitivity to sugar alcohols.
  15. any physical limitations or restrictions that might preclude normal oral hygiene procedures.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03863093


Locations
Layout table for location information
Syrian Arab Republic
Syrian Private University
Damascus, Syrian Arab Republic
Sponsors and Collaborators
Syrian Private University
Investigators
Layout table for investigator information
Principal Investigator: Hala Albonni, DDS MSc Syrian Private University
Study Chair: Hazem Sawaf, DDS MSc PhD Syrian Private University
Publications:

Layout table for additonal information
Responsible Party: Syrian Private University
ClinicalTrials.gov Identifier: NCT03863093    
Other Study ID Numbers: SPU-DN-Perio-2
First Posted: March 5, 2019    Key Record Dates
Last Update Posted: May 14, 2020
Last Verified: May 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Gingivitis
Periodontal Pocket
Infections
Gingival Diseases
Periodontal Diseases
Mouth Diseases
Stomatognathic Diseases
Periodontitis